Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides
- 1 September 2004
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 25 (8), 1023-1032
- https://doi.org/10.1016/j.neurobiolaging.2003.11.001
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Proinflammatory and Vasoactive Effects of Aβ in the CerebrovasculatureAnnals of the New York Academy of Sciences, 2002
- Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's DiseasePharmacological Reviews, 2002
- Neutrophils CD11b and fibroblasts PGE2 are elevated in Alzheimer’s diseaseNeurobiology of Aging, 2002
- Identification of CD40 ligand in Alzheimer’s disease and in animal models of Alzheimer’s disease and brain injuryNeurobiology of Aging, 2002
- Autoantibodies to amyloid-? and Alzheimer's diseaseAnnals of Neurology, 2001
- The biology of the receptor for advanced glycation end products and its ligandsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1999
- Serum auto-antibodies in Alzheimer's diseaseActa Neurologica Scandinavica, 1991
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988